Abstract:This study introduces a 3D spheroid model using NSC‐34 cells for neurodegenerative research. It explores how 3D culture impacts cell morphology, function, and TDP‐43 protein expression and aggregation. Findings reveal reduced protein expression and structural changes, highlighting potential applications in cellular research and drug testing. Three‐dimensional (3D) spheroid models aim to bridge the gap between traditional two‐dimensional (2D) cultures and the complex in vivo tissue environment. These models, created by self‐clustering cells to mimic a 3D environment with surrounding extracellular framework, provide a valuable research tool. The NSC‐34 cell line, generated by fusing mouse spinal cord motor neurons and neuroblastoma cells, is essential for studying neurodegenerative diseases like amyotrophic lateral sclerosis (ALS), where abnormal protein accumulation, such as TAR‐DNA‐binding protein 43 (TDP‐43), occurs in affected nerve cells. However, NSC‐34 behavior in a 3D context remains underexplored, and this study represents the first attempt to create a 3D model to determine its suitability for studying pathology. We generated NSC‐34 spheroids using a nonadhesive hydrogel‐based template and characterized them for 6 days. Light microscopy revealed that NSC‐34 cells in 3D maintained high viability, a distinct round shape, and forming stable membrane connections. Scanning electron microscopy identified multiple tunnel‐like structures, while ultrastructural analysis highlighted nuclear bending and mitochondria alterations. Using inducible GFP‐TDP‐43‐expressing NSC‐34 spheroids, we explored whether 3D structure affected TDP‐43 expression, localization, and aggregation. Spheroids displayed nuclear GFP‐TDP‐43 expression, albeit at a reduced level compared with 2D cultures and generated both TDP‐35 fragments and TDP‐43 aggregates. This study sheds light on the distinctive behavior of NSC‐34 in 3D culture, suggesting caution in the use of the 3D model for ALS or TDP‐43 pathologies. Yet, it underscores the spheroids' potential for investigating fundamental cellular mechanisms, cell adaptation in a 3D context, future bioreactor applications, and drug penetration studies. Research Highlights 3D spheroid generation: NSC‐34 spheroids, developed using a hydrogel‐based template, showed high viability and distinct shapes for 6 days. Structural features: advanced microscopy identified tunnel‐like structures and nuclear and mitochondrial changes in the spheroids. Protein dynamics: the study observed how 3D structures impact TDP‐43 behavior, with altered expression but similar aggregation patterns to 2D cultures. Research implications: this study reveals the unique behavior of NSC‐34 in 3D culture, suggests a careful approach to use this model for ALS or TDP‐43 pathologies, and highlights its potential in cellular mechanism research and drug testing applications.

Simple 3D spheroid cell culture model for studies of prion infection

A NSC‐34 cell line‐derived spheroid model: Potential and challenges for in vitro evaluation of neurodegeneration

Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids

Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt–Jakob disease

Deposition pattern and subcellular distribution of disease-associated prion protein in cerebellar organotypic slice cultures infected with scrapie

PrP(Sc) of Scrapie 263K Propagates Efficiently in Spleen and Muscle Tissues with Protein Misfolding Cyclic Amplification.

Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions

A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds

Neural cell engraftment therapy for sporadic Creutzfeldt-Jakob disease restores neuroelectrophysiological parameters in a cerebral organoid model

Organoids for modeling prion diseases

Development of a methodology for large-scale production of prions for biological and structural studies

A New Cell Model for Investigating Prion Strain Selection and Adaptation

Sporadic Creutzfeldt-Jakob disease infected human cerebral organoids retain the original human brain subtype features following transmission to humanized transgenic mice

Understanding Intra-Species and Inter-Species Prion Conversion and Zoonotic Potential Using Protein Misfolding Cyclic Amplification

Human tripartite cortical network model for temporal assessment of alpha-synuclein aggregation and propagation in Parkinson's Disease

A Three-Dimensional Culture System with Matrigel Promotes Purified Spiral Ganglion Neuron Survival and Function In Vitro

Re-Infection of the Prion from the Scrapie-Infected Cell Line Smb-S15 in Three Strains of Mice, Cd1, C57bl/6 and Balb/C

A unified model for the origins of spongiform degeneration and other neuropathological features in prion diseases

Potential Therapeutic Use of Stem Cells for Prion Diseases

Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of transmissible and rapidly progressive neurodegenerative diseases including Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI) in humans, bovine spongiform encephalopathy (BSE) in cattle, scrapi

A Three-Dimensional Alzheimer’s Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1